21 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26191366	66	Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors.	Indiana University School of Medicine
24035092	2	Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B.	Saint John'S University
24012179	30	Calix[4]arene methylenebisphosphonic acids as inhibitors of protein tyrosine phosphatase 1B.	National Academy of Sciences of Ukraine
23713581	75	A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.	Indiana University School of Medicine
22705189	24	Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.	Imperial College
21116447	65	Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.	Indiana University School of Medicine
20538467	21	Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.	Purdue University
17543532	46	5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.	Universit£
11741477	37	Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.	University of Waterloo
19889539	49	Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.	University of California
20000419	51	Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.	Incyte
20015646	3	Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes.	National Academy of Sciences of Ukraine
19810703	102	Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.	University of Miami
18457385	41	Recent developments in fragment-based drug discovery.	Astex Therapeutics
16759857	59	Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.	Procter & Gamble Pharmaceuticals
32787087	215	Highly Potent and Selective	Purdue University
10464006	22	PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes.	Wyeth-Ayerst Research